Navigation Links
World's largest respiratory genetics study launches on World COPD Day
Date:11/14/2012

Researchers from the Universities of Nottingham and Leicester are leading the largest ever study of the genetics relating to lung disease.

The project will investigate what determines an individual's lung health and why smoking harms the lungs of some people more than others and will use health information held by UK Biobank, a major national resource holding health information from half a million volunteers.

The study, funded by the Medical Research Council (MRC) and also involving scientists at St George's, University of London, is aiming to shed light on why some people are genetically more prone to suffer from lung disease, particularly chronic obstructive pulmonary disease (COPD).

COPD includes conditions such as chronic bronchitis and emphysema and is the sixth most common cause of death in the UK (around 30,000 deaths per year). It affects approximately 900,000 people in the UK and costs the NHS 150m every year. At present, avoiding taking up smoking or, for those who already smoke, stopping smoking remain the most effective ways to prevent COPD.

The World Health Organisation (WHO) estimates that COPD is the 4th leading cause of death worldwide but it is predicted to move into 3rd place in the near future. The new project is being launched on Wednesday November 14, which is World COPD Day.

The research aims to discover the genes which affect lung function and also those which may affect the chances of developing lung disease for both smokers and non-smokers. It will also investigate whether genes play a part in the ability, or failure, to maintain good lung health for smokers and non-smokers. The researchers will also be able to investigate genetic factors that may affect the likelihood of an individual becoming addicted to smoking.

The study, which is called UK BiLEVE (UK Biobank Lung Exome Variant Evaluation), will be one of the first projects to make use of UK Biobank, the world's largest resource of its kind.

All UK Biobank participants have already had their lung function measured and given information about their smoking habits, past and present. In this study, researchers will use anonymous data from 50,000 of these participants to determine genetic variants associated with susceptibility to COPD. They will look at both rare and common single nucleotide polymorphisms (tiny variations in genes) in the participants' DNA and the lung function of those who are heavy smokers and those who have never smoked.

Leading the research is Professor Ian Hall, Dean of The University of Nottingham's Medical School. He said: "We currently know very little about why there is such a wide difference in lung health, even among smokers. We believe genetic factors play an important role so we're extremely excited about using the unique resource of Biobank to test this theory in detail. This study couldn't be done anywhere else in the world."

Professor David Lomas, Chair of the MRC Population and Systems Medicine Board, said: "We know that smoking is unhealthy for anyone but we know little about why the lungs of most smokers are seriously affected, while those of some seem to stay relatively healthy. If we knew more about the genetics that cause this variation we would be better able to direct treatments to those who are most at risk and have an increased chance of developing drugs to target this type of lung disease."

Professor Sir Rory Collins, UK Biobank Principal Investigator, said: "We are extremely grateful to the half a million people throughout Britain who went out of their way to join UK Biobank. Their commitment will provide key insights into a wide range of illnesses that kill and cause pain and suffering. Last week we heard of plans to use the resource to study dementia. This week UK Biobank helps scientists tackle a serious lung condition. UK Biobank will become a key resource to improve health in the 21st century. We are grateful to the MRC, Wellcome Trust and Department of Health for having the vision to back such an initiative."


'/>"/>

Contact: Emma Thorne
emma.thorne@nottingham.ac.uk
44-011-595-15793
University of Nottingham
Source:Eurekalert

Related medicine news :

1. Worlds largest meeting of ear, nose, and throat doctors
2. Largest review of management and treatment of Barretts dysplasia and adenocarcinoma
3. HIV suppression not as good as previously thought, largest study of viral-load blood tests show
4. OnPage Provides Secure, Rapid Response at New England’s Largest Catholic Hospital
5. Smallest, Largest Fetuses at Higher Risk of Stillbirth
6. Womens Respiratory Symptoms May Vary With Menstrual Cycle
7. Respiratory symptoms vary according to stage of menstrual cycle
8. Increase in respiratory symptoms following volcanic eruption
9. Water pipe smoking has the same respiratory effects as smoking cigarettes
10. Butter flavoring in microwave popcorn, thought safe for food industry workers, is respiratory hazard
11. Incan Girls Mummy Yields Evidence of Respiratory Woes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... VA (PRWEB) , ... August 23, 2017 , ... The Stevie® Awards have announced the ... Business Awards , the world’s premier business awards competition. , Nominees in the 2017 IBAs ... determined by a points system based on the total number of awards won in the ...
(Date:8/23/2017)... ... August 23, 2017 , ... Boling ... returned home to Indiana, and is now seeing patients at Boling Vision Center’s ... specializes in the diagnosis and treatment of eye disease, medical retina, high-technology cataract ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... Academy of Orthopaedic Surgeons , points out that therapeutic modalities (physical therapy) is ... injury. According to the report, a wider scope of physical therapy options is ...
(Date:8/22/2017)... ... August 22, 2017 , ... Western ... spoke at a popular international aesthetics conference for medical professionals about the positive ... patients’ health and his growing practice. , Dr. George K. Ibrahim ...
(Date:8/22/2017)... ... ... Glass is new to the Texas market, but is proudly managed by widely recognized All ... models, in Grand Prairie, TX, located in the center of the DFW Metroplex, the fourth ... for the past 40 years with 32 convenient locations in Texas, Nevada and California resulting ...
Breaking Medicine News(10 mins):
(Date:8/14/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... for the second quarter ending June 30, 2017. ... advanced stages of preparing for our pivotal Phase 3 ... Chaim Lebovits , President and Chief Executive Officer ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 million ... continuing operations Second-quarter 2017 ... million Second-quarter 2017 Sterile ... Second-quarter 2017 adjusted diluted earnings ... to $0.93 Second-quarter 2017 ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty ... 2017.  All comparisons, unless otherwise noted, are to the quarter ... Second Quarter 2017 Highlights include: ... of 3.5% Total prescriptions dispensed of 220,000, ... versus 7.6% Gross profit per prescription ...
Breaking Medicine Technology: